{
    "2019-02-25": [
        [
            {
                "time": "2018-03-15",
                "original_text": "Big Pharma to testify in Senate drug pricing hearing",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Senate",
                        "drug pricing",
                        "hearing"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2019-02-12",
                "original_text": "Novartis In-Licenses Rights to Heart Candidate From Ionis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "Ionis",
                        "Heart Candidate",
                        "In-Licenses"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-01",
                "original_text": "Roche (RHHBY) to Acquire Spark Therapeutics for $4.8 Billion",
                "features": {
                    "keywords": [
                        "Roche",
                        "Spark Therapeutics",
                        "Acquire",
                        "$4.8 Billion"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-13",
                "original_text": "Novartis aims to pump up cardio business with Ionis deal",
                "features": {
                    "keywords": [
                        "Novartis",
                        "cardio",
                        "business",
                        "Ionis",
                        "deal"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-04",
                "original_text": "Roche bets $4.3 bln on Spark in gene therapy move",
                "features": {
                    "keywords": [
                        "Roche",
                        "Spark",
                        "gene therapy",
                        "$4.3 bln"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-15",
                "original_text": "Detailed Research: Economic Perspectives on Novartis AG, Proteostasis Therapeutics, Williams-Sonoma, Magna International, YRC Worldwide, and Delek Logistics Partners â€” What Drives Growth in Today's Competitive Landscape",
                "features": {
                    "keywords": [
                        "Research",
                        "Economic Perspectives",
                        "Novartis",
                        "Proteostasis",
                        "Growth"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "retail",
                        "industrial",
                        "logistics"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-02-14",
                "original_text": "Novartis licenses rights to RNA-targeting cardio drug from Ionis",
                "features": {
                    "keywords": [
                        "Novartis",
                        "RNA-targeting",
                        "cardio",
                        "drug",
                        "Ionis"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-03-05",
                "original_text": "[$$] Stocks to watch: Persimmon, General Electric, Centamin, Spark",
                "features": {
                    "keywords": [
                        "Stocks",
                        "watch",
                        "Persimmon",
                        "General Electric",
                        "Centamin",
                        "Spark"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "real estate",
                        "industrial",
                        "mining",
                        "healthcare"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}